{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:43:10Z","timestamp":1792446190268,"version":"4.5.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["1087 PSAU\/2024\/R\/1445"],"award-info":[{"award-number":["1087 PSAU\/2024\/R\/1445"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Lung cancer remains the leading cause of cancer-related mortality worldwide. With approximately 2.2 million new cases and 1.8 million deaths annually, it contributes to 18% of all cancer fatalities. The high mortality rate, limited accessibility to affordable treatments, and the emergence of drug resistance necessitated the development of novel therapeutic strategies. In this study, we employed an HTVS, SP and XP-based molecular docking and MM\/GBSA calculations to identify a potential multitargeted drug candidate from the DrugBank library against five key (Penta) lung cancer-associated proteins, including CDK2 (1AQ1), Transferase(1JWH, 1K3A), Oxidoreductase (4XZL) and Signalling (2DVJ) enzymes that led to the identification of Otamixaban, exhibiting favourable docking and MM\/GBSA scores ranging from \u221211.841 to \u22126.52, and \u221269.96 to \u221245.22 kcal\/mol. Molecular Interaction Fingerprints analysis was performed to gain deeper insights into its binding interactions that reveal key residues with high interaction frequencies, including 12VAL, 8LEU, 7PHE, 6LYS, 5ASP, 5GLN, and 5GLU. Pharmacokinetic evaluations confirmed drug-likeness, and its ADMET properties were consistent with standard drug approval benchmarks, QM computations using DFT further reinforced the stability and reactivity of the identified compound. The thermodynamic role of water molecules in ligand binding was assessed through 5 ns WaterMap analysis, supporting the hypothesis that Otamixaban effectively interacts with the binding pockets of multiple target proteins. Further, a 100-ns MD simulation was conducted to ensure the stability and efficacy of the drug candidate under physiological conditions in an explicit TIP3P water environment. The results demonstrated minimal structural deviations and fluctuations, with strong intermolecular interactions persisting throughout the simulation. Further evaluation of 1000 simulation frames from trajectories provided comprehensive insights into the total complex energy and binding free energy via MM\/GBSA calculations, reinforcing the potential of Otamixaban as a robust multitargeted drug candidate. Despite these promising computational findings, experimental validation through in vitro and in vivo studies is crucial to confirm its therapeutic efficacy and clinical viability.<\/jats:p>","DOI":"10.1371\/journal.pone.0334013","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:34:01Z","timestamp":1760031241000},"page":"e0334013","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins"],"prefix":"10.1371","volume":"20","author":[{"given":"Hanadi M.","family":"Baeissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahani","family":"Bakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afnan Mohammed","family":"Shakoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadir","family":"Sindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6145-4837","authenticated-orcid":true,"given":"Randa Mohammed","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0180-3441","authenticated-orcid":true,"given":"Mohammad Azhar","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel A.","family":"Alsufyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Hamed","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Ishaq A. Khayyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misbahuddin","family":"Rafeeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2499-3700","authenticated-orcid":true,"given":"Deeba Shamim","family":"Jairajpuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"pone.0334013.ref001","volume-title":"Global cancer observatory: cancer today","author":"J Ferlay","year":"2020"},{"issue":"2","key":"pone.0334013.ref002","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"C de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pone.0334013.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874079001508010001","article-title":"Tobacco consumption and oral, pharyngeal and lung cancers","volume":"8","author":"MA Bassiony","year":"2015","journal-title":"TOCJ"},{"issue":"7","key":"pone.0334013.ref004","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"AM Filho","year":"2025","journal-title":"Int J Cancer"},{"issue":"1","key":"pone.0334013.ref005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer","volume":"85","author":"JA Barta","year":"2019","journal-title":"Ann Glob Health"},{"issue":"1","key":"pone.0334013.ref006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40880-016-0135-x","article-title":"Epidemiology of lung cancer and approaches for its prediction: a systematic review and analysis","volume":"35","author":"AK Dubey","year":"2016","journal-title":"Chin J Cancer"},{"key":"pone.0334013.ref007","doi-asserted-by":"crossref","first-page":"133872","DOI":"10.1016\/j.ijbiomac.2024.133872","article-title":"Reporting multitargeted potency of Tiaprofenic acid against lung cancer: molecular fingerprinting, MD simulation, and MTT-based cell viability assay studies","volume":"276","author":"S Ahmad","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"pone.0334013.ref008","article-title":"Multitargeted molecular dynamic understanding of butoxypheser against SARS-CoV-2: an in silico study","volume":"17","author":"S Ahmad","year":"2022","journal-title":"Nat Product Commun"},{"issue":"4","key":"pone.0334013.ref009","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4103\/jcrt.JCRT_473_17","article-title":"A clinico-epidemiological, pathological, and molecular study of lung cancer in Northwestern India","volume":"16","author":"HS Darling","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"pone.0334013.ref010","doi-asserted-by":"crossref","DOI":"10.4103\/ijc.IJC_449_19","article-title":"Molecularly targeted therapies in non-small cell lung cancer: the evolving role of tyrosine kinase inhibitors","volume":"56","author":"DC Doval","year":"2019","journal-title":"Indian J Cancer"},{"issue":"6","key":"pone.0334013.ref011","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.molonc.2014.06.005","article-title":"Tumour heterogeneity and the evolution of polyclonal drug resistance","volume":"8","author":"RA Burrell","year":"2014","journal-title":"Mol Oncol"},{"issue":"9","key":"pone.0334013.ref012","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"A Leiter","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"pone.0334013.ref013","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.53350\/pjmhs211582350","article-title":"Tumor diagnosis by genetic markers protein P-53, p16, C-MYC, N-MYC, protein K-Ras, and gene her-2 Neu is this possible","volume":"15","author":"HA Al-hassany","year":"2021","journal-title":"Pakistan J Med Health Sci"},{"issue":"5","key":"pone.0334013.ref014","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1080\/07391102.2021.2021993","article-title":"Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2","volume":"41","author":"MK Yadav","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"10","key":"pone.0334013.ref015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nsb1097-796","article-title":"Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2","volume":"4","author":"AM Lawrie","year":"1997","journal-title":"Nat Struct Biol"},{"issue":"19","key":"pone.0334013.ref016","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1093\/emboj\/20.19.5320","article-title":"Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme","volume":"20","author":"K Niefind","year":"2001","journal-title":"EMBO J"},{"issue":"12","key":"pone.0334013.ref017","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nsb721","article-title":"Structure and autoregulation of the insulin-like growth factor 1 receptor kinase","volume":"8","author":"S Favelyukis","year":"2001","journal-title":"Nat Struct Biol"},{"issue":"6","key":"pone.0334013.ref018","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nsmb1241","article-title":"Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK","volume":"14","author":"Y Kobashigawa","year":"2007","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"pone.0334013.ref019","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/cmdc.201500393","article-title":"Structural determinants of the selectivity of 3-benzyluracil-1-acetic acids toward human enzymes aldose reductase and AKR1B10","volume":"10","author":"FX Ruiz","year":"2015","journal-title":"ChemMedChem"},{"issue":"3","key":"pone.0334013.ref020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s11030-023-10648-0","article-title":"Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study","volume":"28","author":"S Ahmad","year":"2024","journal-title":"Mol Divers"},{"issue":"6","key":"pone.0334013.ref021","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/1061186X.2024.2347358","article-title":"An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives","volume":"32","author":"S Ahmad","year":"2024","journal-title":"J Drug Target"},{"issue":"19","key":"pone.0334013.ref022","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1080\/07391102.2022.2146202","article-title":"In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical Cancer","volume":"41","author":"S Ahmad","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"pone.0334013.ref023","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted cancer therapies: background, advances and challenges","volume":"22","author":"H Jin","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0334013.ref024","doi-asserted-by":"crossref","first-page":"132332","DOI":"10.1016\/j.ijbiomac.2024.132332","article-title":"Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis","volume":"270","author":"S Ahmad","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"pone.0334013.ref025","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1080\/07391102.2023.2209673","article-title":"Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and in-vitro study","volume":"42","author":"S Ahmad","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"pone.0334013.ref026","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.compbiolchem.2018.02.008","article-title":"Multiple grid arrangement improves ligand docking with unknown binding sites: application to the inverse docking problem","volume":"73","author":"T Ban","year":"2018","journal-title":"Comput Biol Chem"},{"key":"pone.0334013.ref027","doi-asserted-by":"crossref","first-page":"142343","DOI":"10.1016\/j.ijbiomac.2025.142343","article-title":"Probing the multitargeted potency of Theodrenaline and its comparative evaluation with Crizotinib against transferase, hydrolase, signalling, and apoptosis-related proteins to overcome lung cancer drug resistance","volume":"308","author":"S Ahmad","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"pone.0334013.ref028","first-page":"125","volume-title":"Fundamentals of molecular modeling in drug design. Computer Aided Drug Design (CADD): From ligand-based methods to structure-based approaches","author":"MK Tripathi","year":"2022"},{"key":"pone.0334013.ref029","doi-asserted-by":"crossref","first-page":"141703","DOI":"10.1016\/j.ijbiomac.2025.141703","article-title":"Evaluating the polypharmacological potency of FEDPN from ChEMBL BioAssays against lung cancer EGFR, ALK, TrkA and KRAS proteins","volume":"306","author":"S Ahmad","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"pone.0334013.ref030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.53388\/MDM202508008","article-title":"RCSB Protein Data Bank: revolutionising drug discovery and design for over five decades","volume":"8","author":"S Ahmad","year":"2025","journal-title":"Med Data Min"},{"key":"pone.0334013.ref031","article-title":"The RCSB protein data bank: integrative view of protein, gene and 3D structural information","volume":"45","author":"PW Rose","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"pone.0334013.ref032","volume-title":"Maestro","author":"S Maestro","year":"2024"},{"key":"pone.0334013.ref033","volume-title":"Schr\u00f6dinger Suite 2024 Protein Preparation Wizard","author":"S Release","year":"2024"},{"issue":"2","key":"pone.0334013.ref034","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"MP Jacobson","year":"2004","journal-title":"Proteins"},{"issue":"5","key":"pone.0334013.ref035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/0929867330666230309143711","article-title":"Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumor angiogenesis","volume":"31","author":"AA Shah","year":"2024","journal-title":"Curr Med Chem"},{"issue":"12","key":"pone.0334013.ref036","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules","volume":"21","author":"JC Shelley","year":"2007","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"pone.0334013.ref037","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/ja00214a001","article-title":"The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin","volume":"110","author":"WL Jorgensen","year":"1988","journal-title":"J Am Chem Soc"},{"issue":"2","key":"pone.0334013.ref038","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions","volume":"7","author":"MHM Olsson","year":"2011","journal-title":"J Chem Theory Comput"},{"key":"pone.0334013.ref039","volume-title":"LigPrep","author":"S Release","year":"2024"},{"key":"pone.0334013.ref040","volume-title":"Receptor grid generation","author":"S Release","year":"2024"},{"key":"pone.0334013.ref041","volume-title":"Glide: Schr\u00f6dinger","author":"S Release","year":"2024"},{"key":"pone.0334013.ref042","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-981-19-9605-4_3","article-title":"Natural product-based drug designing for treatment of human parasitic diseases","volume-title":"Natural product based drug discovery against human parasites","author":"S Ahmad","year":"2023"},{"issue":"9","key":"pone.0334013.ref043","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1080\/07391102.2022.2060308","article-title":"Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study","volume":"41","author":"S Ahmad","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"pone.0334013.ref044","volume-title":"Schr\u00f6dinger Release 2024","author":"S QikProp","year":"2024"},{"issue":"4","key":"pone.0334013.ref045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"CA Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"issue":"1","key":"pone.0334013.ref046","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/17460441.2023.2267015","article-title":"The application of WaterMap-guided structure-based virtual screening in novel drug discovery","volume":"19","author":"AA Kaczor","year":"2024","journal-title":"Expert Opin Drug Discov"},{"key":"pone.0334013.ref047","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA. Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, 2006.","DOI":"10.1109\/SC.2006.54"},{"key":"pone.0334013.ref048","volume-title":"Molecular dynamics system","author":"S Release","year":"2024"},{"issue":"18","key":"pone.0334013.ref049","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.3390\/molecules27186034","article-title":"Macrophage-targeted punicalagin nanoengineering to alleviate methotrexate-induced neutropenia: a molecular docking, DFT, and MD simulation analysis","volume":"27","author":"R Karwasra","year":"2022","journal-title":"Molecules"},{"issue":"18","key":"pone.0334013.ref050","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences","volume":"113","author":"AD Bochevarov","year":"2013","journal-title":"Int J of Quantum Chemistry"},{"key":"pone.0334013.ref051","volume-title":"Jaguar","author":"S Release","year":"2024"},{"issue":"5","key":"pone.0334013.ref052","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1021\/acs.jctc.7b00176","article-title":"Assessing DFT-D3 damping functions across widely used density functionals: can we do better?","volume":"13","author":"J Witte","year":"2017","journal-title":"J Chem Theory Comput"},{"key":"pone.0334013.ref053","volume-title":"A general SCF theory","author":"R Carb\u00f3","year":"2012"},{"issue":"10","key":"pone.0334013.ref054","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1063\/1.449880","article-title":"Direct inversion in the iterative subspace (DIIS) optimization of open-shell, excited-state, and small multiconfiguration SCF wave functions","volume":"84","author":"TP Hamilton","year":"1986","journal-title":"J Chem Physics"},{"key":"pone.0334013.ref055","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-814421-3.00021-X","volume-title":"Computer-aided prediction of pharmacokinetic (ADMET) properties","author":"B Chandrasekaran","year":"2018"},{"issue":"43","key":"pone.0334013.ref056","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and Dynamics of the TIP3P, SPC, and SPC\/E Water Models at 298 K","volume":"105","author":"P Mark","year":"2001","journal-title":"J Phys Chem A"},{"issue":"1","key":"pone.0334013.ref057","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00268977200100031","article-title":"NpT-ensemble Monte Carlo calculations for binary liquid mixtures","volume":"23","author":"IR McDonald","year":"1972","journal-title":"Molecular Physics"},{"issue":"11","key":"pone.0334013.ref058","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","article-title":"What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery?","volume":"16","author":"T Tuccinardi","year":"2021","journal-title":"Expert Opin Drug Discov"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0344592","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000}}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:34:10Z","timestamp":1760031250000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334013"}},"subtitle":[],"editor":[{"given":"Peter Mbugua","family":"Njogu,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0334013","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}